G01N 2800/322
Orthostatic hypertension or syncope
G01N2800/322 (Orthostatic hypertension or syncope) appears on 2 US grants and 9 published applications in this corpus.
Search patents in G01N- Granted patents
- 2
- Published applications
- 9
- Assignees
- 6
- Inventors
- 17
- Latest grant
- 30 Sep 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 2 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor30 Sep 2014US 8,846,324 B2Celltrend GmbH
- Biomarkers for diabetes, obesity, and/or hypertension14 Jan 2014US 8,628,912 B2Northeastern University
- Postural orthostatic tachycardia syndrome and crth224 Sep 2026US 2026/0287597 A1Amerimmune LLC
- Postural Orthostatic Tachycardia Syndrome and CRTH216 Jun 2022US 2022/0187316 A1Amerimmune LLC
- Assessment of risk of hypertension and methods based thereon29 Oct 2015US 2015/0308939 A1
- Biomarkers for the diagnosis, prognosis, assessment and therapy stratification of syncope30 Apr 2015US 2015/0119271 A1B.R.A.H.M.S GmbH
- Method for diagnosing hypertension as well as cardiomyopathies10 Oct 2013US 2013/0266974 A1Celltrend GmbH
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.